GLABF
Price
$0.55
Change
-$0.00 (-0.00%)
Updated
Aug 6 closing price
Capitalization
33.45M
VKTX
Price
$38.73
Change
+$0.84 (+2.22%)
Updated
Aug 11, 10:43 AM (EDT)
Capitalization
4.26B
72 days until earnings call
Interact to see
Advertisement

GLABF vs VKTX

Header iconGLABF vs VKTX Comparison
Open Charts GLABF vs VKTXBanner chart's image
GEMINA LABORATORIES
Price$0.55
Change-$0.00 (-0.00%)
Volume$19.5K
Capitalization33.45M
Viking Therapeutics
Price$38.73
Change+$0.84 (+2.22%)
Volume$18.7K
Capitalization4.26B
GLABF vs VKTX Comparison Chart in %
Loading...
GLABF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GLABF vs. VKTX commentary
Aug 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLABF is a Hold and VKTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 11, 2025
Stock price -- (GLABF: $0.55 vs. VKTX: $37.89)
Brand notoriety: GLABF and VKTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLABF: 217% vs. VKTX: 175%
Market capitalization -- GLABF: $33.45M vs. VKTX: $4.26B
GLABF [@Biotechnology] is valued at $33.45M. VKTX’s [@Biotechnology] market capitalization is $4.26B. The market cap for tickers in the [@Biotechnology] industry ranges from $93.98B to $0. The average market capitalization across the [@Biotechnology] industry is $1.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLABF’s FA Score shows that 0 FA rating(s) are green whileVKTX’s FA Score has 0 green FA rating(s).

  • GLABF’s FA Score: 0 green, 5 red.
  • VKTX’s FA Score: 0 green, 5 red.
According to our system of comparison, VKTX is a better buy in the long-term than GLABF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLABF’s TA Score shows that 4 TA indicator(s) are bullish while VKTX’s TA Score has 5 bullish TA indicator(s).

  • GLABF’s TA Score: 4 bullish, 2 bearish.
  • VKTX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both GLABF and VKTX are a good buy in the short-term.

Price Growth

GLABF (@Biotechnology) experienced а +4.09% price change this week, while VKTX (@Biotechnology) price change was +15.94% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +22.37%. For the same industry, the average monthly price growth was +31.89%, and the average quarterly price growth was +19.43%.

Reported Earning Dates

VKTX is expected to report earnings on Oct 22, 2025.

Industries' Descriptions

@Biotechnology (+22.37% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VKTX($4.26B) has a higher market cap than GLABF($33.5M). GLABF YTD gains are higher at: 0.696 vs. VKTX (-5.840). GLABF has higher annual earnings (EBITDA): -3.73M vs. VKTX (-212.42M). VKTX has more cash in the bank: 808M vs. GLABF (15K). GLABF has less debt than VKTX: GLABF (244K) vs VKTX (878K). GLABF has higher revenues than VKTX: GLABF (10.9K) vs VKTX (0).
GLABFVKTXGLABF / VKTX
Capitalization33.5M4.26B1%
EBITDA-3.73M-212.42M2%
Gain YTD0.696-5.840-12%
P/E RatioN/AN/A-
Revenue10.9K0-
Total Cash15K808M0%
Total Debt244K878K28%
FUNDAMENTALS RATINGS
VKTX: Fundamental Ratings
VKTX
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
48
Fair valued
PROFIT vs RISK RATING
1..100
68
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GLABFVKTX
RSI
ODDS (%)
Bullish Trend 4 days ago
45%
Bearish Trend 4 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
60%
Bearish Trend 4 days ago
83%
Momentum
ODDS (%)
Bullish Trend 4 days ago
57%
Bullish Trend 4 days ago
82%
MACD
ODDS (%)
Bullish Trend 4 days ago
44%
Bullish Trend 4 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
40%
Bullish Trend 4 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
50%
Bullish Trend 4 days ago
85%
Advances
ODDS (%)
Bullish Trend 6 days ago
83%
Bullish Trend 4 days ago
81%
Declines
ODDS (%)
N/A
Bearish Trend 14 days ago
86%
BollingerBands
ODDS (%)
N/A
Bearish Trend 4 days ago
81%
Aroon
ODDS (%)
Bearish Trend 4 days ago
52%
Bullish Trend 4 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
GLABF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CWXZF6.850.18
+2.70%
Doman Building Materials Group Ltd.
JBFCF3.80N/A
N/A
Jollibee Foods Corp.
TGAAF9.12N/A
N/A
Target Global Acquisition I Corp.
BUDZ0.03N/A
-0.63%
WEED, Inc.
NCBDF35.95-0.55
-1.51%
Bandai Namco Holdings, Inc.

GLABF and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLABF has been loosely correlated with ELVAF. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if GLABF jumps, then ELVAF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLABF
1D Price
Change %
GLABF100%
N/A
ELVAF - GLABF
33%
Loosely correlated
N/A
VANI - GLABF
29%
Poorly correlated
+1.47%
WHWK - GLABF
23%
Poorly correlated
-2.78%
VKTX - GLABF
20%
Poorly correlated
+6.55%
ENTO - GLABF
8%
Poorly correlated
-6.20%
More

VKTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VKTX has been loosely correlated with CRNX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if VKTX jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VKTX
1D Price
Change %
VKTX100%
+6.55%
CRNX - VKTX
46%
Loosely correlated
-3.69%
SYRE - VKTX
46%
Loosely correlated
N/A
LRMR - VKTX
45%
Loosely correlated
-2.19%
GPCR - VKTX
45%
Loosely correlated
+0.68%
ROIV - VKTX
44%
Loosely correlated
-0.52%
More